Christopher Petry,Benson Gikanga,Hung-Wei Chih,Jun Liu
申请号：
US15336578
公开号：
US20170137535A1
申请日:
2016.10.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Pharmaceutical formulations comprising monoclonal anti-Factor D antibodies, and their production and use for the treatment of complement-associated ocular diseases are disclosed. The formulations include pre-lyophilized, lyophilized and reconstituted stable liquid formulations of anti-Factor D antibodies, including lampalizumab.
